
Op-Ed: An omicron-specific vaccine sounds like a good idea. But it's not
Pfizer/BioNTech and Moderna have both begun clinical trials with an omicron-specific vaccine. Sounds good in theory, given that the majority of infections in the United States are with the omicron variant. However, there are numerous reason why such a product will not provide any additional benefits beyond the vaccines that are already available.